Hi All, We're pleased to announce the release of our package 'CausalR', which provides functions for causal reasoning (causal network analysis). The idea is to explain sets of observed endpoints by reasoning through causal interaction networks, so for example this type of analysis can be used to uncover the top regulators of high-throughput transcriptomics data.
So far the use of these techniques has largely been limited to the commercial domain. We hope CausalR and the increasing availability of causal biological interaction data in the public domain will generate interest in their further development in the academic community also. We would be very pleased to discuss potential collaborations to that end, and to receive any other feedback about the package. All being well a publication will appear in the coming months, describing use cases and giving test input gene signatures along with a working public causal network. Best regards, Glyn ________________________________ This e-mail was sent by GlaxoSmithKline Services Unlimited (registered in England and Wales No. 1047315), which is a member of the GlaxoSmithKline group of companies. The registered address of GlaxoSmithKline Services Unlimited is 980 Great West Road, Brentford, Middlesex TW8 9GS. _______________________________________________ Bioc-devel@r-project.org mailing list https://stat.ethz.ch/mailman/listinfo/bioc-devel
